Resmi Charalel
Vascular & Interventional Radiology · New York, NYNPI 1558653980
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 10 manufacturers, the largest accounting for just 23.8%. 2025 is the largest year on record at $14,208, more than ten times the $50 reported in 2021.
Across 44 payments — averaging $652.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Siemens Medical Solutions USA, Inc.$7K
- Guerbet LLC$6K
- Trisalus Life Sciences, Inc.$6K
- GE HealthCare$3K
- Embolx, Inc.$3K
- Instylla, Inc.$3K
- plus $563 from 4 others
Across 4 payments — averaging $45,430 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Instylla, Inc.$182K
What the payments were for
- Consulting fees$16,62158%
- Speaking & faculty fees$3,60013%
- Grants$1010%
- Travel & lodging$5,71320%
- Food & beverage$2,6959%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Siemens Medical Solutions USA, Inc. | 4 | $6,830 |
| Guerbet LLC | 6 | $6,077 |
| Trisalus Life Sciences, Inc. | 15 | $5,584 |
| GE HealthCare | 6 | $3,394 |
| Embolx, Inc. | 1 | $3,300 |
| Instylla, Inc. | 6 | $2,984 |
| Bard Peripheral Vascular, Inc. | 2 | $203 |
| Histosonics, Inc. | 1 | $172 |
| Galvanize Therapeutics, Inc | 1 | $140 |
| Sirtex Medical Inc | 2 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRINAV INFUSION SYSTEM$5,281
- Cryocare CS$3,830
- Instylla Delivery Kit$2,875
- INSTYLLA MICROCATHETER$2,125
- Lipiodol$1,631
- EMBRACE HYDROGEL EMBOLIC SYSTEM (HES)$750
- INSTYLLA MICROCATHETER 1.2$750
- Porter$190
- ALIYA SYSTEM$140
How this compares
$28,731 in reported general payments places this provider in the 85th percentile of 306 vascular & interventional radiology providers in New York.
See all vascular & interventional radiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular & interventional radiology in New York
- Edward KimNew York$831K
- Robert LooksteinNew York$515K
- Rahul PatelNew York$275K
- Aaron FischmanNew York$240K
- Philip MeyersNew York$238K
- Abigail FalkNew York$214K
- Robert RosenNew York$199K
- Asad BaigNew York$137K
- Joshua WeintraubNew York$137K
- Joseph ShamsNew York$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.